These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 23033255

  • 1. Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L.
    Drug Metab Dispos; 2013 Jan; 41(1):60-71. PubMed ID: 23033255
    [Abstract] [Full Text] [Related]

  • 2. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA, Jones JP, Katayama J, Kaspera R, Jiang Y, Freiwald S, Smith E, Walker GS, Totah RA.
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [Abstract] [Full Text] [Related]

  • 3. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E, Wu Z, Shon JC, Liu KH.
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
    Xu M, Ju W, Hao H, Wang G, Li P.
    Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J, Liu D, Zhou X, Chen A, Jiang Z, Ye X, Liu M, Wang X.
    Phytomedicine; 2018 Jan 15; 39():137-145. PubMed ID: 29433675
    [Abstract] [Full Text] [Related]

  • 8. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM, Wu Z, O Y, Lee JH, Oh S, Song GY, Liu KH.
    Drug Metab Dispos; 2017 Jul 15; 45(7):765-769. PubMed ID: 28461575
    [Abstract] [Full Text] [Related]

  • 9. Effects of cytochrome P450 inhibitors on peroxidase activity.
    Martinkova M, Kubickova B, Stiborova M.
    Neuro Endocrinol Lett; 2012 Jul 15; 33 Suppl 3():33-40. PubMed ID: 23353841
    [Abstract] [Full Text] [Related]

  • 10. Characterization of intestinal and hepatic P450 enzymes in cynomolgus monkeys with typical substrates and inhibitors for human P450 enzymes.
    Yoda N, Emoto C, Date S, Kondo S, Miyake M, Nakazato S, Umehara K, Kashiyama E.
    Xenobiotica; 2012 Aug 15; 42(8):719-30. PubMed ID: 22324396
    [Abstract] [Full Text] [Related]

  • 11. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole.
    Matsumoto S, Hirama T, Matsubara T, Nagata K, Yamazoe Y.
    Drug Metab Dispos; 2002 Nov 15; 30(11):1240-5. PubMed ID: 12386130
    [Abstract] [Full Text] [Related]

  • 12. Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2.
    Lafite P, Dijols S, Zeldin DC, Dansette PM, Mansuy D.
    Arch Biochem Biophys; 2007 Aug 15; 464(2):155-68. PubMed ID: 17470359
    [Abstract] [Full Text] [Related]

  • 13. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN, Dykstra J, Roberts EM, Jayanti VK, Hickman D, Uchic J, Yao Y, Surber B, Thomas S, Granneman GR.
    Drug Metab Dispos; 1999 Aug 15; 27(8):902-8. PubMed ID: 10421617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
    Lee E, Kim JH, Shon JC, Wu Z, Kim HJ, Gim M, Lee T, Liu KH.
    Drug Metab Pharmacokinet; 2018 Jun 15; 33(3):159-163. PubMed ID: 29759885
    [Abstract] [Full Text] [Related]

  • 16. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.
    Lee KS, Kim SK.
    J Appl Toxicol; 2013 Feb 15; 33(2):100-8. PubMed ID: 21915887
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.
    Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S.
    Life Sci; 2004 Apr 16; 74(22):2769-79. PubMed ID: 15043991
    [Abstract] [Full Text] [Related]

  • 18. Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant.
    Zhao T, Chen Y, Wang D, Wang L, Dong P, Zhao S, Wang C, Meng Q, Sun H, Liu K, Wu J.
    Cardiovasc Drugs Ther; 2022 Feb 16; 36(1):121-129. PubMed ID: 33411110
    [Abstract] [Full Text] [Related]

  • 19. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
    Leow JWH, Verma RK, Lim ABH, Fan H, Chan ECY.
    Eur J Pharm Sci; 2021 Sep 01; 164():105889. PubMed ID: 34044117
    [Abstract] [Full Text] [Related]

  • 20. Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.
    Evangelista EA, Kaspera R, Mokadam NA, Jones JP, Totah RA.
    Drug Metab Dispos; 2013 Dec 01; 41(12):2087-94. PubMed ID: 24021950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.